Digitek Plaintiffs Want 2nd Look At Class Cert.

Law360, New York (June 10, 2010, 1:27 PM EDT) -- Plaintiffs who lost a bid for class certification in multidistrict litigation over the recall of Actavis Inc. and Mylan Inc.'s heart drug Digitek have asked the judge to reconsider his decision, saying he did not understand what they want from their cases.

The judge seized on a few unusual claims from unsophisticated putative class members — like a request that an enema be reimbursed — and ignored what the plaintiffs actually want to be compensated for, they said in a motion filed Tuesday in the U.S....
To view the full article, register now.